Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial
LE Lundorff, BH Jønsson, P Sjøgren - Palliative medicine, 2009 - journals.sagepub.com
Cognitive impairment seems to be highly prevalent in patients with advanced cancer.
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial.
LE Lundorff, BH Jønsson, P Sjøgren - Palliative Medicine, 2009 - search.ebscohost.com
Cognitive impairment seems to be highly prevalent in patients with advanced cancer.
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil for attentional and psychomotor dysfunction in advanced cancer: A double-blind, randomised, cross-over trial.
LE Lundorff, BH Jønsson, P Sjøgren - Palliative Medicine, 2009 - psycnet.apa.org
Cognitive impairment seems to be highly prevalent in patients with advanced cancer.
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial.
LE Lundorff, BH Jønsson, P Sjøgren - Palliative Medicine, 2009 - europepmc.org
Cognitive impairment seems to be highly prevalent in patients with advanced cancer.
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial
LE Lundorff, BH Jønsson, P Sjøgren - Palliative Medicine, 2009 - search.proquest.com
Cognitive impairment seems to be highly prevalent in patients with advanced cancer.
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial
LE Lundorff, BH Jønsson, P Sjøgren - 2009 - pubmed.ncbi.nlm.nih.gov
Cognitive impairment seems to be highly prevalent in patients with advanced cancer.
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …
Modafinil, a novel vigilance and wake-promoting agent, may be an alternative treatment. We …